{"transactions":[{"id":3190254,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":150239,"kind":"person","name":"Cartwright Daniel A","position":1,"cik":"0001532231","reported_name":"Cartwright Daniel A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-04-02T00:31:32.000Z","date":"2020-03-30","kind":"grant","acquired":true,"shares":151500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023."}],"balance_after":151500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":151500},"source":{"system":"sec-edgar","filing":"0001387131-20-003590","document":"cartwright-form4_033020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713120003590/cartwright-form4_033020.xml","form_type":"4"}},{"id":3190253,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":150239,"kind":"person","name":"Cartwright Daniel A","position":1,"cik":"0001532231","reported_name":"Cartwright Daniel A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Stock Units","published_at":"2020-04-02T00:31:32.000Z","date":"2020-03-30","kind":"grant","acquired":true,"shares":151500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":151500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":151500},"source":{"system":"sec-edgar","filing":"0001387131-20-003590","document":"cartwright-form4_033020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713120003590/cartwright-form4_033020.xml","form_type":"4"}},{"id":3426475,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":150239,"kind":"person","name":"Cartwright Daniel A","position":1,"cik":"0001532231","reported_name":"Cartwright Daniel A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-08-31T01:48:05.000Z","date":"2019-08-28","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Underlying shares vest as follows: 73,334 shares on the first anniversary date of the grant, 73,333 shares on the second anniversary date of the grant, and 73,333 shares on the third anniversary date of the grant."}],"balance_after":220000,"derivative":{"exercise_price":2.73,"exercise_date":"2020-08-28","expiration_date":"2029-08-28","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001387131-19-006602","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119006602/ownership.xml","form_type":"4"}},{"id":3738944,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":150239,"kind":"person","name":"Cartwright Daniel A","position":1,"cik":"0001532231","reported_name":"Cartwright Daniel A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-12-11T01:02:02.000Z","date":"2018-12-06","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":180000,"derivative":{"exercise_price":0.38,"exercise_date":"2012-10-21","expiration_date":"2021-10-21","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001387131-18-006726","document":"cartwright-form4_120618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006726/cartwright-form4_120618.xml","form_type":"4"}},{"id":3738943,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":150239,"kind":"person","name":"Cartwright Daniel A","position":1,"cik":"0001532231","reported_name":"Cartwright Daniel A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2018-12-11T01:02:02.000Z","date":"2018-12-06","kind":"sale","acquired":false,"shares":40000,"price":4.57,"value":182800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.44 to $4.68, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001387131-18-006726","document":"cartwright-form4_120618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006726/cartwright-form4_120618.xml","form_type":"4"}},{"id":3738942,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":150239,"kind":"person","name":"Cartwright Daniel A","position":1,"cik":"0001532231","reported_name":"Cartwright Daniel A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2018-12-11T01:02:02.000Z","date":"2018-12-06","kind":"exercise","acquired":true,"shares":40000,"price":0.38,"value":15200.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001387131-18-006726","document":"cartwright-form4_120618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006726/cartwright-form4_120618.xml","form_type":"4"}},{"id":3769134,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":150239,"kind":"person","name":"Cartwright Daniel A","position":1,"cik":"0001532231","reported_name":"Cartwright Daniel A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-11-13T12:35:20.000Z","date":"2018-11-07","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":220000,"derivative":{"exercise_price":0.38,"exercise_date":"2012-10-21","expiration_date":"2021-10-21","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001387131-18-006074","document":"cartwright-form4_110718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006074/cartwright-form4_110718.xml","form_type":"4"}},{"id":3769133,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":150239,"kind":"person","name":"Cartwright Daniel A","position":1,"cik":"0001532231","reported_name":"Cartwright Daniel A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2018-11-13T12:35:20.000Z","date":"2018-11-07","kind":"sale","acquired":false,"shares":40000,"price":4.85,"value":194000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.68 to $4.955, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001387131-18-006074","document":"cartwright-form4_110718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006074/cartwright-form4_110718.xml","form_type":"4"}},{"id":3769132,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":150239,"kind":"person","name":"Cartwright Daniel A","position":1,"cik":"0001532231","reported_name":"Cartwright Daniel A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2018-11-13T12:35:20.000Z","date":"2018-11-07","kind":"exercise","acquired":true,"shares":40000,"price":0.38,"value":15200.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001387131-18-006074","document":"cartwright-form4_110718.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006074/cartwright-form4_110718.xml","form_type":"4"}},{"id":3991460,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":150239,"kind":"person","name":"Cartwright Daniel A","position":1,"cik":"0001532231","reported_name":"Cartwright Daniel A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-03-19T21:42:05.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Underlying shares vest as follows: 56,667 shares on the first anniversary date of the grant, 56,667 shares on the second anniversary date of the grant, and 56,666 shares on the third anniversary date of the grant."}],"balance_after":170000,"derivative":{"exercise_price":5.16,"exercise_date":"2019-03-15","expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001387131-18-001123","document":"cartwright-form4_031518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118001123/cartwright-form4_031518.xml","form_type":"4"}},{"id":4381756,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":150239,"kind":"person","name":"Cartwright Daniel A","position":1,"cik":"0001532231","reported_name":"Cartwright Daniel A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2017-03-17T22:36:54.000Z","date":"2017-03-15","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Underlying shares vest as follows: 56,667 shares on the first anniversary date of the grant, 56,667 shares on the second anniversary date of the grant, and 56,666 shares on the third anniversary date of the grant."}],"balance_after":170000,"derivative":{"exercise_price":6.83,"exercise_date":"2018-03-15","expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001387131-17-001463","document":"cartwright-form4_031517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713117001463/cartwright-form4_031517.xml","form_type":"4"}}]}